[Obstructive sleep apnea syndrome in woman: Knowing its specificities for a better management].

Autor: Sediri S; Université de Lille, CHU, institut cœur-poumon, médecine vasculaire-HTA, 59037 Lille cedex, France. Electronic address: sediri.souad@ymail.com., Madika AL; Université de Lille, CHU, institut cœur-poumon, médecine vasculaire-HTA, 59037 Lille cedex, France., Baguet JP; Cardiologie, 97422 Le Tampon (Réunion), Réunion; Université Joseph-Fourier, Inserm U1039, 38400 Grenoble, France., Mallart A; Université de Lille, CHU, institut cœur-poumon, unité du sommeil, 59037 Lille cedex, France., Charley-Monaca C; Université de Lille, CHU, unité de sommeil, service de neurophysiologie clinique, 59037 Lille cedex, France., Mounier Vehier C; Université de Lille, CHU, institut cœur-poumon, médecine vasculaire-HTA, 59037 Lille cedex, France.
Jazyk: francouzština
Zdroj: Presse medicale (Paris, France : 1983) [Presse Med] 2018 Jun; Vol. 47 (6), pp. 499-509.
DOI: 10.1016/j.lpm.2018.03.018
Abstrakt: Cardiovascular diseases are the first cause of death in women. Their frequency is underestimated because of their atypical feminine clinical presentation. The pathway "heart, arteries and women", initiated at Lille's hospital center in 2013, was designed to improve pluridisciplinar approaches for women. Thus, obstructive sleep apnea (OSA), known as a metabolic risk factor, was studied in several works. In post-menopausal women with cardiovascular risk, frequency of OSA seems underestimated. Clinical presentation of OSA in feminine patients can be misleading, and its screening seems essential, in light of its major cardiovascular impact.
(Copyright © 2018 Elsevier Masson SAS. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: